Literature DB >> 9496478

Segmental liver resections for hilar cholangiocarcinoma.

M Nagino1, Y Nimura, J Kamiya, M Kanai, K Uesaka, N Hayakawa, H Yamamoto, S Kondo, H Nishio.   

Abstract

BACKGROUNDS/AIMS: Liver resection for hilar cholangiocarcinoma is now popular, and combined en bloc resection of the caudate lobe has become general practice, especially in Japan and some European countries. However, surgical procedure is not yet standardized, and many problems concerning surgical treatment of this disease still remain unsolved.
METHODOLOGY: From April 1977 to December 1996, 173 patients with hilar cholangiocarcinoma were treated at The First Department of Surgery, Nagoya University Hospital. Of the 173 patients, 138 patients underwent surgical resection, including 124 liver resections and 14 bile duct resections.
RESULTS: Several kinds of hepatic segmentectomy with en bloc resection of the caudate lobe were performed in the 124 patients: 109 underwent hepatic lobectomy or more extensive resection including central bisegmentectomy; 15 received resection of one or less segment of the liver. Aggressive resections, including combined portal vein and liver resection (n = 41) and hepatopan-creatoduodenectomy (n = 16), were applied to advanced hilar cholangiocarcinoma. The hospital death rate in hepatectomized patients was 9.7% (12/124). The 3- and 5-year rates for the 97 patients with curative hepatectomy were 42.7%, and 25.8%, respectively.
CONCLUSIONS: Aggressive liver resection improves survival of patients with hilar cholangiocarcinoma. Resection procedures should be designed based on a precise diagnosis of the extent of carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9496478

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  24 in total

1.  Different approaches to caudate lobectomy with "curettage and aspiration" technique using a special instrument PMOD: a report of 76 cases.

Authors:  Shu-You Peng; Jiang-Tao Li; Yi-Ping Mou; Ying-Bin Liu; Yu-Lian Wu; He-Qing Fang; Li-Ping Cao; Li Chen; Xiu-Jun Cai; Cheng-Hong Peng
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

3.  Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.

Authors:  Tatsuharu Yamada; Toshiyuki Arai; Masato Nagino; Koji Oda; Junichi Shoda; Hiroshi Suzuki; Yuichi Sugiyama; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-06-17       Impact factor: 3.445

4.  Preoperative evaluation with T-staging system for hilar cholangiocarcinoma.

Authors:  Ru-Fu Chen; Zhi-Hua Li; Jia-Jia Zhou; Jie Wang; Ji-Sheng Chen; Qing Lin; Qi-Bing Tang; Ning-Fu Peng; Zhi-Peng Jiang; Quan-Bo Zhou
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

5.  Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C.

Authors:  W T Kassahun; B Günl; A Tannapfel; F R Ungemach; J Hauss; G Abraham
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-15       Impact factor: 3.000

6.  Spiegel's lobe bile ducts often drain into the right hepatic duct or its branches: study using drip-infusion cholangiography-computed tomography in 179 consecutive patients.

Authors:  Masahiro Kitami; Gen Murakami; Saiho Ko; Kei Takase; Masahiro Tuboi; Haruo Saito; Yoshiyuki Nakajima; Shoki Takahashi
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

8.  Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.

Authors:  Yasuji Seyama; Keiichi Kubota; Keiji Sano; Tamaki Noie; Tadatoshi Takayama; Tomoo Kosuge; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

10.  Value of multidetector row CT in the assessment of longitudinal extension of cholangiocarcinoma: correlation between MDCT and microscopic findings.

Authors:  Yoshiki Senda; Hideki Nishio; Koji Oda; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Teiichi Sugiura; Yoshie Shimoyama; Yuji Nimura; Masato Nagino
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.